Other headlinesAgfa integrates peerVue productsBarco extends distribution alliance
Medison unveils new ob/gyn unit
High-resolution 3D/4D imaging distinguishes a new dedicated ob/gyn ultrasound system from competitors, according to its South Korean developer, Medison. The Accuvix V20 Prestige, which debuted last week at the ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) meeting in Hamburg, Germany, is optimized for evaluating obstetrical, pelvic, and abdominal anatomy. It provides 360-degree articulated monitor arm, ergonomic key grouping, and a 19-inch flat LCD with haze eliminating filter.
Agfa integrates peerVue products
Agfa HealthCare will resell two products developed by peerVue as integral parts of its Impax 6.0 PACS. One is a workflow, quality, and communication product, called qiVue. The other is a teaching file and content management product, called caseVue. By allowing critical results reporting, peer review, emergency department discrepancy management, and technologist quality control, as well as the generation of teaching files, Agfa says the newly integrated products will enable radiology departments to meet requirements for accreditation by the American College of Radiology.
Barco extends distribution alliance
Barco has signed Fineman GMBH to resell its medical displays in Germany. Fineman A/S, the parent company of the newly signed Ratingen, Germany-based distributor, has been selling Barco products in Denmark for several years.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.